(Q24247007)

1 reference

inferred from title

author

Leonard H van den Berg

2

object named as

Leonard H van den Berg

0 references

author name string

Ivo N van Schaik

1

0 references

Rob de Haan

3

0 references

Marinus Vermeulen

Cochrane Database of Systematic Reviews

4

0 references

publication date

20 April 2005

0 references

published in

0 references

cites work

Multifocal motor neuropathy improved by IVIg: randomized, double-blind, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

Intravenous immunoglobulin therapy in multifocal motor neuropathy: a double-blind, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

Treatment of multifocal motor neuropathy with high dose intravenous immunoglobulins: a double blind, placebo controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

Multifocal motor neuropathy: long-term clinical and electrophysiological assessment of intravenous immunoglobulin maintenance treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

Long term follow up of multifocal motor neuropathy with conduction block under treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

Multifocal motor neuropathy with conduction block misdiagnosed as multiple entrapment neuropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

Bilateral phrenic neuropathy as a presenting feature of multifocal motor neuropathy with conduction block

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

Multifocal motor neuropathy with conduction block: a study of 24 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

Abnormalities of axonal excitability are not generalized in early multifocal motor neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

Multifocal motor neuropathy: response to human immune globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

Plasmapheresis in multifocal motor neuropathy: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

Clinical and neurophysiological assessment of immunoglobulin therapy in five patients with multifocal motor neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

Effect of high-dose intravenous immunoglobulin on amyotrophic lateral sclerosis and multifocal motor neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

Measuring quality of life in stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

Suppressor cell function after intravenous gammaglobulin treatment in adult chronic idiopathic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

Use of human intravenous immunoglobulin in lower motor neuron syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

Clinical immunopharmacology of autoimmune neuropathies and myopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

Early or deferred zidovudine therapy in HIV-infected patients without an AIDS-defining illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

Physiology of conduction block in multifocal motor neuropathy and other demyelinating neuropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

A syndrome of asymmetric limb weakness with motor conduction block

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

Single fibre electromyography in multifocal motor neuropathy with persistent conduction blocks

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

Reversal of lymphocyte activation in vivo in the Kawasaki syndrome by intravenous gammaglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

Human immunoglobulin treatment of multifocal motor neuropathy and polyneuropathy associated with monoclonal gammopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

CD4 and CD8 subpopulation changes during high dose intravenous immunoglobulin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

Chronic motor neuropathies: response to interferon-beta1a after failure of conventional therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

Electrophysiological improvement after intravenous immunoglobulin in motor neuropathy with multifocal conduction block

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

Cost-utility analysis of intravenous immunoglobulin and prednisolone for chronic inflammatory demyelinating polyradiculoneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

Long term effect of intravenous immunoglobulins and oral cyclophosphamide in multifocal motor neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

Central motor conduction time in patients with multifocal motor conduction block.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

High-dose intravenous immunoglobulin therapy in multifocal motor neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

Multifocal motor neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

Multifocal motor neuropathy: clinical and immunological features and response to IVIg in relation to the presence and degree of motor conduction block.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

What is the best diagnostic index of conduction block and temporal dispersion?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

Multifocal acquired demyelinating neuropathy masquerading as motor neuron disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

Motor neuropathy with multifocal conduction block

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

Risks associated with the use of intravenous immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

A computer simulation of conduction block: effects produced by actual block versus interphase cancellation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

How long is IVIg effective in multifocal motor neuropathy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

Demyelination and axonal loss in multifocal motor neuropathy: distribution and relation to weakness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

The long-term effect of intravenous immunoglobulin treatment in multifocal motor neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

Disease severity in multifocal motor neuropathy and its association with the response to immunoglobulin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

In vitro effects of polyvalent immunoglobulin for intravenous use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

Progressive arm weakness and tonic hand spasm from multifocal motor neuropathy in the brachial plexus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

Peripheral neuropathies and anti-glycolipid antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

Therapy with Intravenous Immunoglobulins: Complications and Side-Effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

Rapidly progressive multifocal motor neuropathy with phrenic nerve paralysis: effect of nocturnal assisted ventilation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

Multifocal motor neuropathy mimicking motor neuron disease: nine cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

Immunosuppressive treatment of motor neuron syndromes. Attempts to distinguish a treatable disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

7 January 2021

Immunosuppressive treatment of motor neuron syndromes

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

7 January 2021

Monofocal motor neuropathy responsive to intravenous immunoglobulins

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

7 January 2021

Multifocal motor neuropathy presenting with respiratory failure

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

7 January 2021

Multifocal motor neuropathy: diagnostic criteria that predict the response to immunoglobulin treatment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

7 January 2021

A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

7 January 2021

Immunosuppressive treatment in multifocal motor neuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

7 January 2021

Monofocal motor neuropathy: Improvement with intravenous immunoglobulin

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

7 January 2021

Anterior interosseous nerve and multifocal motor neuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

7 January 2021

Consensus criteria for the diagnosis of multifocal motor neuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

7 January 2021

Sequential electrodiagnostic abnormalities in acute inflammatory demyelinating polyradiculoneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

7 January 2021

Conduction block in clinical practice

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

7 January 2021

Multifocal motor neuropathy: electrodiagnostic features

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

7 January 2021

Persistent increased threshold of electrical stimulation selective to motor nerve in multifocal motor neuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

7 January 2021

AAEM case report #30: multifocal motor neuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

7 January 2021

Multifocal motor neuropathy presenting as ophthalmoplegia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

7 January 2021

Muscle hypertrophy in multifocal motor neuropathy is associated with continuous motor unit activity

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

7 January 2021

Chronic relapsing brachial plexus neuropathy with persistent conduction block

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

7 January 2021

Multifocal acquired demyelinating sensory and motor neuropathy: the Lewis-Sumner syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

7 January 2021

Natural history of 46 patients with multifocal motor neuropathy with conduction block

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

7 January 2021

Multifocal motor neuropathy: clinical and electrophysiological findings

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

7 January 2021

[Multifocal motor neuropathy: diagnosis and differential diagnosis]

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

7 January 2021

[Immunoglobulin therapy of chronic inflammatory neuropathies]

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

7 January 2021

Motor neuropathies mimicking amyotrophic lateral sclerosis/motor neuron disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

7 January 2021

Intravenous immunoglobulin treatment in multifocal motor neuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

7 January 2021

Intravenous immunoglobulin for multifocal motor neuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

7 January 2021

79(th) ENMC International Workshop: multifocal motor neuropathy. 14-15 April 2000, Hilversum, The Netherlands

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

7 January 2021

Multifocal motor neuropathy and asymptomatic Hashimoto's thyroiditis: first report of an association

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

7 January 2021

A misdiagnosis of multifocal motor neuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

7 January 2021

Mechanism of intravenous immune globulin therapy in antibody-mediated autoimmune diseases

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

7 January 2021

Strokes, thromboembolic events, and IVIg: rare incidents blemish an excellent safety record

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

7 January 2021

Multifocal motor neuropathy: decrease in conduction blocks and reinnervation with long-term IVIg

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

7 January 2021

The administration of guanidine in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

7 January 2021

Multifocal demyelinating neuropathy with persistent conduction block

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

7 January 2021

Multifocal demyelinating motor neuropathy: cranial nerve involvement and immunoglobulin therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

7 January 2021

Intravenous immunoglobulin treatment in patients with motor neuron syndromes associated with anti-GM1 antibodies: a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

7 January 2021

Progression of multifocal motor neuropathy during apparently successful treatment with human immunoglobulin

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

7 January 2021

Improvement of multifocal motor neuropathy during long-term weekly treatment with human immunoglobulin

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

7 January 2021

Diagnostic value of GM1 antibodies in motor neuron disorders and neuropathies: a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

7 January 2021

Multifocal motor neuropathy with conduction block and Campylobacter jejuni

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

7 January 2021

Multifocal motor neuropathy with conduction block after Campylobacter jejuni enteritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

7 January 2021

Electrophysiologic findings in multifocal motor neuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

7 January 2021

Pulsed high-dose dexamethasone is not effective in patients with multifocal motor neuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

7 January 2021

Magnetic resonance imaging of the brachial plexus in patients with multifocal motor neuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

7 January 2021

Deterioration of multifocal motor neuropathy after plasma exchange

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

7 January 2021

Electrophysiologic findings in multifocal motor neuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

7 January 2021

Impact of neurologic signs and symptoms on functional status in peripheral neuropathies

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

7 January 2021

Treatment of multifocal motor neuropathy with interferon-beta1A

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

7 January 2021

Multifocal motor neuropathy improved by IVIg

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

7 January 2021

Worsening of multifocal motor neuropathy during pregnancy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

7 January 2021

The absence of survival motor neuron 2 gene may play a role in multifocal motor neuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004429.PUB2

7 January 2021